Breaking

Sanofi Snags Vigil Neuroscience for Alzheimer's DrugSo, like, Sanofi, the French drug maker, just dropped $470 million to acquire Vigil Neuroscience, a small biotech company. And get this, they're adding an experimental treatment for...

A Bunch of Docs and Researchers Sue NIH Over Research CutsIn a bold move that's got everyone talking, a group of physicians and researchers working on LGBTQ+ health decided to take the National Institutes...

President Trump’s Medicare agency is on a mission to speed up audits of Medicare Advantage insurers, aiming to recover about $500 million annually for taxpayers. However, these audits are currently tangled up in a...

So, like, mRNA vaccines were super crucial during the whole pandemic thing, right? They helped us combat the worst global crisis in, like, a century and even scored a Nobel Prize. But now, some...

Well, hey there, folks! How's it going on this fine day? We're hanging in there, thank you very much, especially since we've hit the midpoint of the week. I mean, we've made it this...

Sen. Lisa Blunt Rochester shot off a fiery letter to Health Secretary Robert F. Kennedy Jr., demanding some answers about the Centers for Disease Control and Prevention's current leadership situation. She's not too thrilled...

In a pretty big deal, Maryland Gov. Wes Moore went ahead and signed this bill that lets a state board keep working on making prescription drugs cheaper for everyone in the state, not just...

It's a beautiful morning at the Pharmalot campus, where the sun is shining, and a gentle breeze is blowing. The short person is still catching some Z's, and the official mascots are on guard...

News of former President Biden’s aggressive and incurable prostate cancer has really thrown the public for a loop. Like, seriously, no one saw this coming. Apparently, not even Biden himself. Poor guy.Who, What, Where,...

Molecular biologist Chiara Masnovo spent weeks filling out an application for a research fellowship earlier this year. She was 38 weeks pregnant and starting a new job at the time, which made the process...

So, like, listen up, peeps! Today's scoop is all about the wild world of biotech. If you wanna be in the know about all the science and politics that drive this crazy industry, then...

eGenesis recently brought on board a fresh face, Jay Barth, as their new chief medical officer. Barth previously held the same position at Ascidian Therapeutics, showcasing his expertise in the field. This news is...